328564-08-5

Basic information

• Product Name: 4'-methoxy-7-(prop-2-yn-1-yloxy)isoflavone
• Synonyms: 4'-methoxy-7-(prop-2-yn-1-yloxy)isoflavone
• CAS NO: 328564-08-5
• Molecular Weight: 306.318
• Mol File: 328564-08-5.mol

Chemical Properties

• CAS DataBase Reference: 4'-methoxy-7-(prop-2-yn-1-yloxy)isoflavone(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-methoxy-7-(prop-2-yn-1-yloxy)isoflavone(328564-08-5)
• EPA Substance Registry System: 4'-methoxy-7-(prop-2-yn-1-yloxy)isoflavone(328564-08-5)

Safety Data

• Hazardous Substances Data: 328564-08-5(Hazardous Substances Data)

Upstream product

• 485-72-3 7-Hydroxy-3-(4-methoxy-phenyl)-chromen-4-on 
• 106-96-7 propargyl bromide 
• 487-49-0 1-(2,4-dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone 
• 104-01-8 4-Methoxyphenylacetic acid 
• 108-46-3 recorcinol 

Downstream Products

• 1184948-66-0 C₁₉H₁₄O₄ 

Relevant articles and documents

Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cells

Background Gastric cancer (GC) is the second most common cause of cancer-related death worldwide. Novel anticancer drugs against gastric cancer are urgently needed. Methods Compound 10 was designed and synthesized via a molecular hybridization strategy ba

Formononetin derivative, and preparation method and application thereof

The invention provides a formononetin derivative, and a preparation method and an application thereof. The derivative has a structure shown in the specification. The derivative can be used as an anti-tumor drug and has good anti-tumor activity; and the sy

Combinatorial synthesis of structurally diverse triazole-bridged flavonoid dimers and trimers

Flavonoids are a large family of compounds associated with a broad range of biologically useful properties. In recent years, synthetic compounds that contain two flavonoid units linked together have attracted attention in drug discovery and development projects. Numerous flavonoid dimer systems, incorporating a range of monomers attached via different linkers, have been reported to exhibit interesting bioactivities. From a medicinal chemistry perspective, the 1,2,3-triazole ring system has been identified as a particularly attractive linker moiety in dimeric derivatives (owing to several favourable attributes including proven biological relevance and metabolic stability) and triazole-bridged flavonoid dimers possessing anticancer and antimalarial activities have recently been reported. However, there are relatively few examples of libraries of triazole-bridged flavonoid dimers and the diversity of flavonoid subunits present within these is typically limited. Thus, this compound type arguably remains underexplored within drug discovery. Herein, we report a modular strategy for the synthesis of novel and biologically interesting triazole-bridged flavonoid heterodimers and also very rare heterotrimers from readily available starting materials. Application of this strategy has enabled step-efficient and systematic access to a library of structurally diverse compounds of this sort, with a variety of monomer units belonging to six different structural subclasses of flavonoid successfully incorporated.

A facile synthesis of angular and linear 8/2-methyl furo[2,3-h]/[3,2-g] chromones and angular pyrano[2,3-f] isoflavones from 7-propargyloxy chromones and isoflavones

The Claisen rearrangement of 7-propargyloxy chromones (2a-d) and 7-propargyloxy isoflavones (8a-f) in N,N-Diethylaniline at 195°C gave 8/2-methylfuro[2,3-h]/[3,2-g] chromones (3a-d) and pyrano [2,3-f] isoflavones (9a-f) respectively.